Hand Function pp 251-259 | Cite as

Function Assessment in Metabolic Disorders: Diabetes Mellitus, Hemodialysis, and Gout

  • Feray Soyupek
  • Selami Akkuş


Metabolic diseases affect the function of the hand by making musculoskeletal involvement

Metabolic diseases, including chronic renal failure undergoing hemodialysis, gout, and diabetes mellitus, impair hand function by affecting musculoskeletal system, causing hemodynamic, vascular, or neurological dysfunctions. Carpal tunnel syndrome (CTS), destructive arthropathy, bone cyst, bone erosions, and tendon abnormalities are seen in the patients receiving hemodialysis. Diabetes mellitus is associated with an increased incidence of functional disability. The complications of diabetes mellitus seen in the hand are diabetic stiff hand syndrome, Dupuytren’s disease, CTS, trigger finger, complex regional pain syndrome type-1, and neuropathy. Patients with gout have monosodium urate crystals deposited in the tendon, joints, and nerve. Tophi leads to destructive arthropathy and presents on the fingers and volar surface of the hands. Muscle strength test, range-of-motion evaluation, hand dexterity, and daily activity tests could be conducted to assess the extent of damage in those patients. In this chapter, the musculoskeletal and the other involvements of the hand were mentioned. Additionally, the tests evaluating hand functions and index which were used for evaluating hand disability were reviewed.


Diabetes mellitus Hemodialysis Gout Hand Disability Function 


  1. 1.
    Kessler M, Netter P, Azoulay E, Mayeux D, Péré P, Gaucher A. Dialysis-associated arthropathy: a multicenter survey of 171 patients receiving haemodialysis for over 10 years. Br J Rheumatol. 1992;31:157–62.CrossRefGoogle Scholar
  2. 2.
    Kay J. β2 microglobulin amyloidosis. Int J Experimental Clin Investig. 1997;4:187–211.Google Scholar
  3. 3.
    Kay J, Bardin T. Osteoarticular disorders of renal origin: disease related and iatrogenic. Baillieres Best Pract Res Clin Rheumatol. 2000;14(2):285–305.CrossRefGoogle Scholar
  4. 4.
    Jadoul M, Garbar C, Noël H, Sennesael J, Vanholder R, Bernaert P, Rorive G, Hanique G, van Ypersele de Strihou C. Histological prevalence of beta 2-microglobulin amyloidosis in hemodialysis: a prospective post-mortem study. Kidney Int. 1997;51(6):1928–32.CrossRefGoogle Scholar
  5. 5.
    Scali ST, Huber TS. Treatment strategies for access-related hand ischemia. Semin Vasc Surg. 2011;24(2):128–36.CrossRefGoogle Scholar
  6. 6.
    Malik J, Tuka V, Kasalova Z, Chytilova E, Slavikova M, Clagett P, Davidson I, Dolmatch B, Nichols D, Gallieni M. Understanding the dialysis access steal syndrome. A review of the etiologies, diagnosis, prevention and treatment strategies. J Vasc Access. 2008;9(3):155–66.CrossRefGoogle Scholar
  7. 7.
    Hirasawa Y, Ogura T. Carpal tunnel syndrome in patients on long-term haemodialysis. Scand J Plast Reconstr Surg Hand Surg. 2000;34:373–81.CrossRefGoogle Scholar
  8. 8.
    Nakamoto HA, Ferreira MC, Tustumi F, et al. Sensory testing in patients with hemodialysis-associated carpal tunnel syndrome submitted to surgical decompression. Ann Plast Surg. 2014;72:685–8.CrossRefGoogle Scholar
  9. 9.
    Kurer MH, Baillod RA, Madgwick JC. Musculoskeletal manifestations of amyloidosis. A review of 83 patients on haemodialysis for at least 10 years. J Bone Joint Surg Br. 1991;73:271–6.CrossRefGoogle Scholar
  10. 10.
    Martinez J, Forts P, Falgás J, Martinez E, Mascort I, Plans A, Rotellar E. Carpal tunnel syndrome and chronic hemodialysis. Am J Nephrol. 1985;5(6):476.CrossRefGoogle Scholar
  11. 11.
    Kumar S, Trivedi HL, Smith EK. Carpal tunnel syndrome: a complication of arteriovenous fistula in hemodialysis patients. Can Med Assoc J. 1975;113:1070–2.PubMedPubMedCentralGoogle Scholar
  12. 12.
    Schwarz A, Keller F, Seyfert S, Pöll W, Molzahn M, Distler A. Carpal tunnel syndrome: a major complication in long-term hemodialysis patients. Clin Nephrol. 1984;22:133–7.PubMedGoogle Scholar
  13. 13.
    Namazi H, Majd Z. Carpal tunnel syndrome in patients who are receiving long-term renal hemodialysis. Arch Orthop Trauma Surg. 2007;127(8):725–8.CrossRefGoogle Scholar
  14. 14.
    Flipo RM, Loet L, Siame JL, et al. Destructive arthropathy of the hand in patients treated by long term hemodialysis. Seven cases with pathologic examination. Rev Rheum Engl Ed. 1995;62:241.Google Scholar
  15. 15.
    Maruyama H, Gejyo F, Arakawa M. Clinical studies of destructive spondyloarthropathy in long-term hemodialysis patients. Nephron. 1992;61(1):37–44.CrossRefGoogle Scholar
  16. 16.
    Cotten A, Flipo RM, Boutry N, et al. Natural course of erosive arthropathy of the hand in patients undergoing hemodialysis. Skelet Radiol. 1997;26:20e6.CrossRefGoogle Scholar
  17. 17.
    Kim D, Choi IC, Park JW. Severe destructive tendinopathy in the wrist due to dialysis-related amyloidosis. J Hand Surg Asian Pac Vol. 2017;22(3):376–9.CrossRefGoogle Scholar
  18. 18.
    Uehara K, Hozumi T, Yamakawa K. Spontaneous rupture of the extensor pollicis longus tendon in a patient with hyperparathyroidism undergoing chronic haemodialysis. J Hand Surg Eur Vol. 2013;38(2):213–5.CrossRefGoogle Scholar
  19. 19.
    Rosenfeld N, Rascoff JH. Tendon ruptures of the hand associated with renal dialysis. Plast Reconstr Surg. 1980;65(1):77–9.CrossRefGoogle Scholar
  20. 20.
    Ross LV, Ross GJ, Mesgarzadeh M, Edmonds PR, Bonakdarpour A. Hemodialysis-related amyloidomas of bone. Musculoskeletal Radiol. 1991;178(1):263–5.Google Scholar
  21. 21.
    Sargent MA, Fleming SJ, Chattopadhyay C, Ackrill P, Sambrook P. Bone cysts and hemodialysis-related amyloidosis. Clin Radiol. 1989;40:277–81.CrossRefGoogle Scholar
  22. 22.
    DiRaimondo CR, Casey TT, DiRaimondo CV, Stone WJ. Pathologic fractures associated with idiopathic amyloidosis of bone in hemodialysis patients. Nephron. 1986;43:22–7.CrossRefGoogle Scholar
  23. 23.
    Fitzpatrick DC, Jebson PJ, Madey SM, Steyers CM. Upper extremity musculoskeletal manifestations of dialysis-associated amyloidosis. Iowa Orthop J. 1996;16:135–8.PubMedPubMedCentralGoogle Scholar
  24. 24.
    Lindstedt E, Westling H. Effects of antebrachial cimino-brescia arteriovenous fistula on the local circulation in the hand. Scand J Urol Nephrol. 1975;9:119–24.CrossRefGoogle Scholar
  25. 25.
    Limaye V, Frankham A, Disney A, Pile K. Evaluation of hand function in patients undergoing long term haemodialysis. Ann Rheum Dis. 2001;60(3):278–80.CrossRefGoogle Scholar
  26. 26.
    Duruöz MT, Cerrahoglu L, Dincer-Turhan Y, Kürsat S. Hand function assessment in patients receiving haemodialysis. Swiss Med Wkly. 2003;133(31–32):433–8.PubMedGoogle Scholar
  27. 27.
    Cuppari L, Avesani CM, Mendonça COG. Doenças Renais. In: Cuppari L, editor. Guias de Medicina ambulatorial e hospitalar. Unifesp/Escola Paulista de Medicina, Nutrição. 2nd ed. Manole: São Paulo; 2005. p. 189–220.Google Scholar
  28. 28.
    Fouque D, Kalantar-Zadeh K, Kopple J, Cano N, Chauveau P, Cuppari L, Franch H, Guarnieri G, Ikizler TA, Kaysen G, Lindholm B, Massy Z, Mitch W, Pineda E, Stenvinkel P, Treviño-Becerra A, Wanner C. A proposed nomenclature and diagnostic criteria for protein-energy wasting in acute and chronic kidney disease. Kidney Int. 2008;73:391–8.CrossRefGoogle Scholar
  29. 29.
    Vogt BP, Borges MCC, Goés CR, Caramori JCT. Handgrip strength is an independent predictor of all-cause mortality in maintenance dialysis patients. Clin Nutr. 2016;35(6):1429–33.CrossRefGoogle Scholar
  30. 30.
    Norman K, Stobäus N, Gonzalez MC, Schulzke JD, Pirlich M. Hand grip strength: outcome predictor and marker of nutritional status. Clin Nutr. 2011;30(2):135–42.CrossRefGoogle Scholar
  31. 31.
    Mathiowetz V, Weber K, Volland G, Kashman N. Reliability and validity of grip and pinch strength evaluations. J Hand Surg. 1984;9A:222–6.CrossRefGoogle Scholar
  32. 32.
    Buddenberg LA, Davis C. Test-retest reliability of the Purdue Pegboard test. Am J Occup Ther. 2000;54(5):555–8.CrossRefGoogle Scholar
  33. 33.
    Sollerman C. Assessment of grip function: evaluation of a new test method. Doctoral dissertation. Goteborg: University of Goteborg; 1980.Google Scholar
  34. 34.
    Tander B, Akpolat T, Durmus D, Canturk F. Evaluation of hand functions in hemodialysis patients. Ren Fail. 2007;29(4):477–80.CrossRefGoogle Scholar
  35. 35.
    Chazot C, Chazot I, Charra B, Terrat JC, Vanel T, Calemard E, Ruffet M, Laurent G. Functional study of hands among patients dialysed for more than 10 years. Nephrol Dial Transplant. 1993;8(4):347–51.PubMedGoogle Scholar
  36. 36.
    Branz NR, Newton RA. Hand function in patients on maintenance hemodialysis. Phys Ther. 1988;68(7):1092–7.CrossRefGoogle Scholar
  37. 37.
    Duruo¨z MT, Poiraudeau S, Fermanian J, et al. Development and validation of a rheumatoid hand functional disability scale that assesses functional handicap. J Rheumatol. 1996;23:1167–72.Google Scholar
  38. 38.
    Rehfuss JP, Berceli SA, Barbey SM, He Y, Kubilis PS, Beck AW, Huber TS, Scali ST. The spectrum of hand dysfunction after hemodialysis fistula placement. Kidney Int Rep. 2017;2(3):332–41.CrossRefGoogle Scholar
  39. 39.
    Smith LL, Burnet SP, McNeil JD. Musculoskeletal manifestations of diabetes mellitus. Br J Sports Med. 2003;37:30–5.CrossRefGoogle Scholar
  40. 40.
    Gamstedt A, Holm-Glad J, Ohlson CG, Sundstrom M. Hand abnormalities are strongly associated with the duration of diabetes mellitus. J Intern Med. 1993;234:189.CrossRefGoogle Scholar
  41. 41.
    Casanova JE, Casanova JS, Young MJ. Hand function in patients with diabetes mellitus. South Med J. 1991;84(9):1111–3.CrossRefGoogle Scholar
  42. 42.
    Ramchurn N, Mashamba C, Leitch E, Arutchelvam V, Narayanan K, Weaver J, et al. Upper limb musculoskeletal abnormalities and poor metabolic control in diabetes. Eur J Intern Med. 2009;20:718–21.CrossRefGoogle Scholar
  43. 43.
    Redmond CL, Bain GI, Laslett LL, McNeil JD. Hand syndromes associated with diabetes: impairments and obesity predict disability. J Rheumatol. 2009;36(12):2766–71.CrossRefGoogle Scholar
  44. 44.
    Nathan DM. The pathophysiology of diabetic complications: how much does the glucose hypothesis explain? Ann Intern Med. 1996;124(1 Pt 2):86–9.CrossRefGoogle Scholar
  45. 45.
    Brownlee M. Glycation products and the pathogenesis of diabetic complications. Diabetes Care. 1992;15(12):1835–43.CrossRefGoogle Scholar
  46. 46.
    Rosenbloom AL, Silverstein JH. Connective tissue and joint disease in diabetes mellitus. Endocrinol Metab Clin N Am. 1996;25(2):473–83.CrossRefGoogle Scholar
  47. 47.
    Papanas N, Maltezos E. The diabetic hand: a forgotten complication? J Diabetes Complicat. 2010;24(3):154–62.CrossRefGoogle Scholar
  48. 48.
    Larkin ME, Barnie A, Braffett BH, Cleary PA, Diminick L, Harth J, Gatcomb P, Golden E, Lipps J, Lorenzi G, Mahony C, Nathan DM, Diabetes control and complications trial/epidemiology of diabetes interventions and complications research group. Musculoskeletal complications in type 1 diabetes. Diabetes Care. 2014;37(7):1863–9.CrossRefGoogle Scholar
  49. 49.
    Mustafa KN, Khader YS, Bsoul AK, Ajlouni K. Musculoskeletal disorders of the hand in type 2 diabetes mellitus: prevalence and its associated factors. Int J Rheum Dis. 2016;19(7):730–5.CrossRefGoogle Scholar
  50. 50.
    Ramchurn N, Mashamba C, Leitch E, Arutchelvam V, Narayanan K, Weaver J, Hamilton J, Heycock C, Saravanan V, Kelly C. Upper limb musculoskeletal abnormalities and poor metabolic control in diabetes. Eur J Intern Med. 2009;20(7):718–21.CrossRefGoogle Scholar
  51. 51.
    Sauseng S, Kästenbauer T, Irsigler K. Limited joint mobility in selected hand and foot joints in patients with type 1 diabetes mellitus: a methodology comparison. Diabetes Nutr Metab. 2002;15:1–6.PubMedGoogle Scholar
  52. 52.
    Yosipovitch G, Mukamel M, Karp M. Diabetic hand syndrome in juvenile diabetics. Harefuah. 1990;119(3–4):63–6.PubMedGoogle Scholar
  53. 53.
    Crispin JC, Alcocer-Varela J. Rheumatologic manifestations of diabetes mellitus. Am J Med. 2003;114:753–7.CrossRefGoogle Scholar
  54. 54.
    Ardic F, Soyupek F, Kahraman Y, Yorgancioglu R. The musculoskeletal complications seen in type II diabetics: predominance of hand involvement. Clin Rheumatol. 2003;22(3):229–33.CrossRefGoogle Scholar
  55. 55.
    Chammas M, Bousquet P, Renard E, Poirier JL, Jaffiol C, Allieu Y. Dupuytren’s disease, carpal tunnel syndrome, trigger finger, and diabetes mellitus. J Hand Surg Am. 1995;20(1):109–15.CrossRefGoogle Scholar
  56. 56.
    Arkkila PE, Gautier JF. Musculoskeletal disorders in diabetes mellitus: an update. Best Pract Res Clin Rheumatol. 2003;17:945–70.CrossRefGoogle Scholar
  57. 57.
    Childs SG. Dupuytren’s disease. Orthop Nurs. 2005;24:160–4.PubMedGoogle Scholar
  58. 58.
    Jennings AM, Milner PC, Ward JD. Hand abnormalities are associated with the complications of diabetes in type 2 diabetes. Diabet Med. 1989;6(1):43–7.CrossRefGoogle Scholar
  59. 59.
    Yang CJ, Hsu HY, Lu CH, Chao YL, Chiu HY, Kuo LC. The associations among hand dexterity, functional performance, and quality of life in diabetic patients with neuropathic hand from objective- and patient-perceived measurements. Qual Life Res. 2015;24(1):213–22.CrossRefGoogle Scholar
  60. 60.
    Cetinus E, Buyukbese MA, Uzel M, Ekerbicer H, Karaoguz A. Hand grip strength in patients with type 2 diabetes mellitus. Diabetes Res Clin Pract. 2005;70(3):278–86.CrossRefGoogle Scholar
  61. 61.
    Savas S, Koroglu BK, Koyuncuoglu HR, Uzar E, Celik H, Tamer NM. The effects of the diabetes related soft tissue hand lesions and the reduced hand strength on functional disability of hand in type 2 diabetic patients. Diabetes Res Clin Pract. 2007;77(1):77–83.CrossRefGoogle Scholar
  62. 62.
    Shah KM, Clark BR, McGill JB, Mueller MJ. Upper extremity impairments, pain and disability in patients with diabetes mellitus. Physiotherapy. 2015;101(2):147–54.CrossRefGoogle Scholar
  63. 63.
    American Diabetes Association. Standards of medical care in diabetes. Diabetes Care. 2008;31(Suppl 1):12–54.CrossRefGoogle Scholar
  64. 64.
    Dutch Association of Neurology (NVN), Dutch Association of Clinical Neurophysiology (NVKNF). Guideline polyneuropathy of the Dutch institute for healthcare improvement (CBO). Alphen a/d Rijn: van Zuiden; 2005.Google Scholar
  65. 65.
    Bell-Krotoski JA. Sensibility testing with the Semmes–Weinstein monofilaments. In: Mackin EJ, Callahan AD, Skirven TM, Schneider LH, Osterman AL, editors. Rehabilitation of the hand and upper extremity. 5, vol. 1. St Louis: Mosby; 2002. p. 194–213.Google Scholar
  66. 66.
    NHS National Institute for Clinical Excellence (NICE). Type 2 diabetes prevention and management of foot problems, clinical guideline 10. London: National Institute for Clinical Excellence (NICE); 2004.Google Scholar
  67. 67.
    Mueller MJ. Identifying patients with diabetes mellitus who are at risk for lower-extremity complications: use of Semmes-Weinstein monofilaments. Phys Ther. 1996;76(1):68–71.CrossRefGoogle Scholar
  68. 68.
    Valk GD, de Sonnaville JJ, van Houtum WH, Heine RJ, van Eijk JT, Bouter LM, Bertelsmann FW. The assessment of diabetic polyneuropathy in daily clinical practice: reproducibility and validity of Semmes Weinstein monofi laments examination and clinical neurological examination. Muscle Nerve. 1997;20(1):116–21.CrossRefGoogle Scholar
  69. 69.
    Dros J, Wewerinke A, Bindels PJ, van Weert HC. Accuracy of monofilament testing to diagnose peripheral neuropathy: a systematic review. Ann Fam Med. 2009;7(6):555–8.CrossRefGoogle Scholar
  70. 70.
    Travieso D, Lederman SJ. Assessing subclinical tactual deficits in the hand function of diabetic blind persons at risk for peripheral neuropathy. Arch Phys Med Rehabil. 2007;88(12):1662–72.CrossRefGoogle Scholar
  71. 71.
    Turan Y, Duruöz MT, Aksakalli E, Gürgan A. Validation of Duruöz Hand Index for diabetic hand dysfunction. J Investig Med. 2009;57(8):887–91.CrossRefGoogle Scholar
  72. 72.
    Chiu HY, Hsu HY, Kuo LC, Su FC, Yu HI, Hua SC, Lu CH. How the impact of median neuropathy on sensorimotor control capability of hands for diabetes: an achievable assessment from functional perspectives. PLoS One. 2014;9(4):e94452.CrossRefGoogle Scholar
  73. 73.
    Smith EU, az-Torne C, Perez-Ruiz F, March LM. Epidemiology of gout: an update. Best Pract Res Clin Rheumatol. 2010;24:811–27.CrossRefGoogle Scholar
  74. 74.
    Lottmann K, Chen X, Schadlich PK. Association between gout and all-cause as well as cardiovascular mortality: a systematic review. Curr Rheumatol Rep. 2012;14:195–203.CrossRefGoogle Scholar
  75. 75.
    Scire CA, Manara M, Cimmino MA, Govoni M, Salaffi F, Punzi L, Monti MC, Carrara G, Montecucco C, Matucci-Cerinic M, Minisola G, Study Collaborators KING. Gout impacts on function and health-related quality of life beyond associated risk factors and medical conditions: results from the KING observational study of the Italian Society for Rheumatology (SIR). Arthritis Res Ther. 2013;15(5):R101.CrossRefGoogle Scholar
  76. 76.
    Dalbeth N, Collis J, Gregory K, Clark B, Robinson E, McQueen FM. Tophaceous joint disease strongly predicts hand function in patients with gout. Rheumatology (Oxford). 2007;46(12):1804–7.CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  • Feray Soyupek
    • 1
  • Selami Akkuş
    • 2
  1. 1.Department of Physical Medicine and RehabilitationSüleyman Demirel University HospitalIspartaTurkey
  2. 2.Department of Physical Medicine and Rehabilitation, School of MedicineYıldırım Beyazıt UniversityAnkaraTurkey

Personalised recommendations